While tumours lacking variants in these genes but also BRAF/RAS and NF1 have been dubbed ‘quadruple wild-type’ [9], it is more appropriate to specify those genes that have been tested, e.g. WT for KIT, PDGFRA, NF1 and BRAF/RAS. This evidence concerns the gene KIT and neoplasm.